Carregant...
Randomized Phase II Trials: Time for a New Era in Clinical Trial Design
The classic single-arm oncology phase II trial designs for evaluating an experimental regimen/agent are limited by multiple sources of bias arising from the inability to separate trial effects (such as patient selection, trial eligibility, imaging techniques and assessment schedule, and treatment lo...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2941394/ https://ncbi.nlm.nih.gov/pubmed/20581575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181e2eadf |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|